Conference Coverage

New insights emerge from pediatric chronic cutaneous lupus


 

AT THE SPD ANNUAL MEETING

References

"I love this study," commented SPD President Dr. Beth A. Drolet, professor of dermatology at the Medical College of Wisconsin, Milwaukee. "Your point that if transformation to SLE happens, it’s going to happen quickly – that’s enormously helpful to me clinically."

The study was funded by the SPD. Dr. Arkin reported having no financial conflicts.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Treat systemic sclerosis early and aggressively
MDedge Dermatology
FDA approves blood test for membranous glomerulonephritis
MDedge Dermatology
FVC inadequate when assessing scleroderma lung disease
MDedge Dermatology
Stem-cell transplants growing routine for severe scleroderma
MDedge Dermatology
VIDEO: Slow tapering worked best for stopping SLE immunosuppression
MDedge Dermatology
SLE patients in remission safely stop immunotherapy
MDedge Dermatology
Real-world use supports belimumab clinical trial data
MDedge Dermatology
Trial of sirukumab for lupus nephritis falls flat
MDedge Dermatology
Deaths mar atacicept trial for lupus, but research continues
MDedge Dermatology
Rituximab yielded long-term benefit in lupus nephritis
MDedge Dermatology